HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].

Abstract
The bacterial strains isolated from 490 patients diagnosed as having urinary tract infections (UTIs) in 14 institutions in Japan were collected between August 2004 and July 2005. The susceptibilities of them to many kinds of antimicrobial agents were measured. Of them, 577 strains were estimated as causative bacteria and used for the measurement. The strains consisted of 156 gram-positive bacterial strains (27.0%) and 421 gram-negative bacterial strains (73.0%). Against Staphylococcus aureus, arbekacin (ABK), vancomycin (VCM) showed the strongest activity and prevented the growth of all strains with 2 microg/mL. Against Enterococcus faecalis, ampicillin (ABPC) and VCM showed a strong antibacterial activity. The antibacterial activity of cephems to Escherichia coli was generally good, and especially cefozopran (CZOP) and cefpirome (CPR) showed the strongest activity (MIC90: < or = 125 microg/mL). Quinolone resistant E. coli [MIC of ciprofloxacin (CPFX): > or = 4 microg/mL] was detected at frequency of 18.8%, which was higher than that in the last year. Against Klebsiella pneumoniae, CZOP, meropenem (MEPM), and carumonam (CRMN) showed the strongest activity and prevented the growth of all strains with 0.125 microg/mL or less. The antibacterial activity of the other cephems was relatively good, and decrease in their activity observed in the last year study was not recognized. Against Serratia marcescens, imipenem (IPM) and gentamicin (GM) had the strongest antibacterial activity. Against Proteus mirabilis, CRMN showed the strongest activity and prevented the growth of all strains with 0.125 microg/mL or less. MEPM prevented the growth of all strains with 0.25 microg/mL. Next, cefmenoxime (CMX), ceftazidime (CAZ), CZOP, cefixime (CFIX), cefpodoxime (CPDX), and cefditoren (CDTR) showed a strong activity. The antibacterial activity of the drugs to Pseudomonas aeruginosa was generally low, and MIC90 of all the drugs was ranged from 32 to > 128 microg/mL except IPM and MEPM having 16 microg/mL. The antibacterial activities of CZOP and CAZ were considered to be relatively good on MIC50 comparison (MIC50: 2 microg/mL).
AuthorsYoshiaki Kumamoto, Taiji Tsukamoto, Masanori Matsukawa, Yasuharu Kunishima, Takaoki Hirose, Shiro Shigeta, Osamu Yamaguti, Kei Ishibashi, Tatsuo Suzutani, Hiroshi Yoshida, Yuuji Imafuku, Masaru Murai, Kiyoaki Watanabe, Yoshio Kobayashi, Hiroshi Uchida, Seiji Matsuda, Shinichi Sato, Makoto Fujime, Kazuhiko Fujita, Jun Igari, Toyoko Oguri, Keizo Yamaguchi, Nobuhiko Furuya, Takashi Deguchi, Satoshi Ishihara, Hiroshi Ooe, Toshitsugu Oka, Masaya Kitamura, Yoshifumi Fukuhara, Sadao Kamidono, Soichi Arakawa, Hiromi Kumon, Koichi Monden, Tetsuro Matsumoto, Tetsuro Muratani, Seiji Naito, Toshihisa Egashira, Takatoshi Konishi, Shigeru Kohno, Yoichi Hirakata, Akira Kondo, Junichi Matsuda, Michiko Nakano
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 59 Issue 3 Pg. 177-200 (Jun 2006) ISSN: 0368-2781 [Print] Japan
PMID16913404 (Publication Type: Journal Article)
Chemical References
  • Aminoglycosides
  • Anti-Infective Agents
  • Cephalosporins
  • Gentamicins
  • Quinolones
  • Thienamycins
  • cefozopran
  • Dibekacin
  • carumonam
  • Vancomycin
  • Imipenem
  • Ampicillin
  • cefpodoxime
  • cefditoren
  • Cefixime
  • Ceftizoxime
  • Meropenem
  • Aztreonam
  • arbekacin
  • cefpirome
Topics
  • Aminoglycosides (pharmacology)
  • Ampicillin (pharmacology)
  • Anti-Infective Agents (pharmacology)
  • Aztreonam (analogs & derivatives, pharmacology)
  • Cefixime (pharmacology)
  • Ceftizoxime (analogs & derivatives, pharmacology)
  • Cephalosporins (pharmacology)
  • Dibekacin (analogs & derivatives, pharmacology)
  • Drug Resistance, Bacterial
  • Enterococcus faecalis (drug effects)
  • Escherichia coli (drug effects)
  • Gentamicins (pharmacology)
  • Gram-Negative Bacteria (drug effects)
  • Gram-Positive Bacteria (drug effects)
  • Humans
  • Imipenem (pharmacology)
  • Klebsiella pneumoniae (drug effects)
  • Meropenem
  • Microbial Sensitivity Tests
  • Proteus mirabilis (drug effects)
  • Pseudomonas aeruginosa (drug effects)
  • Quinolones (pharmacology)
  • Serratia marcescens (drug effects)
  • Staphylococcus aureus (drug effects)
  • Thienamycins (pharmacology)
  • Urinary Tract Infections (microbiology)
  • Vancomycin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: